Hers vs Remedy Meds: How Each Handles GLP-1 Medication

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

When the question is specifically about the meds, the useful comparison is not the brand logos but how each service actually gets a GLP-1 into your hands. This PlexusDx Education Hub review looks at Hers and Remedy Meds through the lens of medication handling, then adds the genetic context that shapes any compound. Browse all Peptides & GLP-1 education.

Full head-to-head: PlexusDx vs Remedy Meds →

Disclosure of independence: PlexusDx holds no commercial relationship with Hers, Remedy Meds, or their parent organizations. This review contains no affiliate links, no paid placement, and no referral fees.

Hers and Remedy Meds both dispense GLP-1 therapy through telehealth, but the medication journey, from prescription to refill, carries the details that matter most to a patient. Below we trace how each brand sources and dispenses medication, what the compounded route involves, how titration and follow-up work, and the inherited factor sitting beneath every dose. Information is current as of April 2026.

Hers and its medication pathway

Hers, part of Hims & Hers Health, works as subscription telehealth. After a virtual evaluation and a licensed clinician's review, an eligible patient receives either an FDA-approved brand GLP-1 or a compounded semaglutide or tirzepatide from a licensed compounding pharmacy. The specifics of what it dispenses are maintained at Hers's official website.

Remedy Meds and its medication pathway

Remedy Meds runs telehealth alongside compounded-pharmacy fulfillment, emphasizing the medication side of the service. Its drug menu, membership terms, and totals shift over time, so the current details belong on Remedy Meds's official website at the moment you review your options.

Compounded versus branded: what dispensing means

The word "meds" hides an important fork. A branded, FDA-approved GLP-1 comes from the manufacturer in a fixed presentation, while a compounded version is prepared by a 503A pharmacy against an individual prescription. The active molecule sits in the same pharmacologic family, but concentration, format, and supplies can differ. Understanding which route a brand uses tells you more about your day-to-day experience than the logo does.

Titration, refills, and follow-up

Getting the medication is only the start; managing it is the ongoing part. Most GLP-1 telehealth programs support dose titration over time and offer follow-up for side-effect management, with refills tied to the subscription. How responsive that follow-up is, and whether a physician, nurse practitioner, or physician assistant oversees it, varies between services. Those operational details shape adherence more than any single feature on a marketing page.

The pharmacology behind every dose

No matter which service dispenses it, the compound drives the effect. GLP-1 receptor agonists including semaglutide, liraglutide, and dulaglutide, and the dual GIP/GLP-1 agonist tirzepatide, act on appetite, satiety, and gastric emptying. That mechanism is a property of the molecule, not the brand. The trial record backs the class: STEP for semaglutide in weight management (New England Journal of Medicine, 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024), each with distinct doses and endpoints.

What the meds cost to maintain

Ongoing medication cost across GLP-1 telehealth as of April 2026 tends to fall within a wide band of roughly $200 to $700 or more monthly, shaped by the compound, the plan term, and dispensing fees. Because refills recur, the maintenance cost matters as much as the first month. Verify each brand's current pricing on its own page rather than relying on a figure that may already have changed.

The factor no prescription captures

Every dose acts on inherited biology the prescription itself never records. A variant in GLP1R, the very receptor these compounds bind, together with FTO, MC4R (central to satiety and energy balance), and TCF7L2 (linked to glucose handling), outlines your baseline metabolic terrain. These pathway-level markers do not predict how a specific medication will perform for you, but they describe the ground each dose lands on.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Ahead of any protocol, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2. Test before you invest.

Not affiliated: PlexusDx has no relationship with Hers or Remedy Meds and reviewed both independently.

Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

Disclaimer: This article is educational. PlexusDx is not affiliated with Hers or Remedy Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach in the Weight Management Protocols, or start with the Precision Peptide Genetic Test.

Frequently Asked Questions

Do Hers and Remedy Meds dispense compounded or branded GLP-1?

Both can route prescriptions to licensed compounding pharmacies, and Hers may also dispense FDA-approved branded products depending on the program. Which route applies affects format, supplies, and cost, so confirm on each brand's own site whether your specific medication would be compounded or branded before ordering.

How does dose titration work through these services?

GLP-1 therapy is typically started low and increased gradually to manage side effects. Telehealth programs support this titration through follow-up visits and adjusted refills tied to the subscription. Responsiveness and provider type vary between services, so ask how follow-up and dose changes are handled before committing to a plan.

Does the Precision Peptide Genetic Test change my medication?

No. The test does not prescribe, adjust, or predict response to any medication. It maps pathway-level variants such as FTO and MC4R, and TCF7L2 that describe your baseline biology, giving you and your provider context to inform the conversation around whichever compound you pursue.

What does PlexusDx add on the medication side?

PlexusDx dispenses semaglutide and tirzepatide through its Weight Management Protocols and pairs them with the Precision Peptide Genetic Test for upstream genetic context, mapping FTO, MC4R. That pathway-level layer is what neither Hers nor Remedy Meds provides alongside the medication.

More guidance in the Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.